An observational study conducted by researchers at the University of Texas MD Anderson Cancer Center and the University of Florida (UF), the lead site of the OneFlorida+ PCORnet® Clinical Research Network, showed promising results for the potential of mRNA vaccines to improve health outcomes for people who have advanced lung or skin cancer.
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
Researchers with the OneFlorida+ Clinical Research Network have begun recruiting patients to a national study to learn if several existing prescription and over-the-counter medications can help those with COVID-19 safely manage their symptoms at home and avoid hospitalization. The study is one of several research projects that are part…
